{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:34:24Z","timestamp":1773765264669,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Due to habitual drinking and smoking and advanced age at diagnosis, patients with head and neck squamous cell carcinoma (HNSCC) frequently present with comorbidities. Several comorbidity indices have been developed and validated for HNSCC. However, none have become the standard method. In this study, we developed a new comorbidity index for Japanese patients with HNSCC, which was validated against an independent data set. A Cox proportional hazards analysis of 698 patients identified dementia, connective tissue diseases, and second primary malignancies in the oesophagus, head and neck, lungs, and stomach as prognostic comorbidities for overall survival. The Osaka head and neck comorbidity index (OHNCI) was generated from the weighted points of these comorbidities. In the independent data set, the 5-year overall survival rates for the low, moderate, and high scoring OHNCI groups were 62.1%, 64.3%, and 37.7%, respectively. In the multivariate analysis, the high scoring OHNCI group was an independent prognostic factor for overall survival (hazard ratio: 1.81, 95% confidence interval: 1.05\u20133.13; P\u2009=\u20090.031). The model including the OHNCI exhibited a higher prognostic capability compared to those including other commonly used comorbidity indices. The OHNCI could become the primary choice for comorbidity assessment in patients with HNSCC in Japan.<\/jats:p>","DOI":"10.1038\/s41598-017-07752-1","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T10:52:29Z","timestamp":1501498349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development and validation of a new comorbidity index for patients with head and neck squamous cell carcinoma in Japan"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3135-5635","authenticated-orcid":false,"given":"Yukinori","family":"Takenaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Michiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hanamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Inohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"key":"7752_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/hed.21720","volume":"34","author":"SH Landis","year":"2012","unstructured":"Landis, S. H. et al. Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck. Head Neck. \n                           34, 238\u2013244 (2012).","journal-title":"Head Neck."},{"key":"7752_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.radonc.2013.11.009","volume":"110","author":"CR Boje","year":"2014","unstructured":"Boje, C. R. et al. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database. Radiother Oncol. \n                           110, 91\u201397 (2014).","journal-title":"Radiother Oncol."},{"key":"7752_CR3","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/archotol.128.10.1172","volume":"128","author":"JF Piccirillo","year":"2002","unstructured":"Piccirillo, J. F., Lacy, P. D., Basu, A. & Spitznagel, E. L. Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg. \n                           128, 1172\u20131179 (2002).","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"7752_CR4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3109\/00016489.2014.906750","volume":"134","author":"Y Takenaka","year":"2014","unstructured":"Takenaka, Y. et al. Factors associated with malnutrition in patients with head and neck cancer. Acta Otolaryngol. \n                           134, 1079\u20131085 (2014).","journal-title":"Acta Otolaryngol."},{"key":"7752_CR5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/annonc\/mds540","volume":"24","author":"CH Ryu","year":"2013","unstructured":"Ryu, C. H. et al. Risk factors for non-cancer health events in patients with head and neck squamous cell carcinoma. Ann Oncol. \n                           24, 1049\u20131054 (2013).","journal-title":"Ann Oncol."},{"key":"7752_CR6","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers. Version 2.2016 https\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck_blocks.pdf (2016)."},{"key":"7752_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. \n                           40, 373\u2013383 (1987).","journal-title":"J Chronic Dis."},{"key":"7752_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/00005537-200004000-00011","volume":"110","author":"JF Piccirillo","year":"2000","unstructured":"Piccirillo, J. F. Importance of comorbidity in head and neck cancer. Laryngoscope. \n                           110, 593\u2013602 (2000).","journal-title":"Laryngoscope."},{"key":"7752_CR9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1017\/S0022215112000254","volume":"126","author":"VS Nesic","year":"2012","unstructured":"Nesic, V. S. et al. Comparison of the Adult Comorbidity Evaluation 27 and the Charlson Comorbidity indices in patients with laryngeal squamous cell carcinoma. J Laryngol Otol. \n                           126, 516\u2013524 (2012).","journal-title":"J Laryngol Otol."},{"key":"7752_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0021-9681(74)90017-4","volume":"27","author":"MH Kaplan","year":"1974","unstructured":"Kaplan, M. H. & Feinstein, A. R. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis. \n                           27, 387\u2013404 (1974).","journal-title":"J Chronic Dis."},{"key":"7752_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan, H. et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol \n                           173, 676\u2013682 (2011).","journal-title":"Am J Epidemiol"},{"key":"7752_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1200\/JCO.2010.31.8311","volume":"29","author":"LG Morris","year":"2011","unstructured":"Morris, L. G., Sikora, A. G., Patel, S. G., Hayes, R. B. & Ganly, I. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. \n                           29, 739\u2013746 (2011).","journal-title":"J Clin Oncol."},{"key":"7752_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/archotol.134.6.603","volume":"134","author":"A Sanabria","year":"2008","unstructured":"Sanabria, A. et al. Validation of the Washington University Head and Neck Comorbidity Index in a cohort of older patients. Arch Otolaryngol Head Neck Surg. \n                           134, 603\u2013607 (2008).","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"7752_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.radonc.2013.07.005","volume":"110","author":"CR Boje","year":"2014","unstructured":"Boje, C. R. Impact of comorbidity on treatment outcome in head and neck squamous cell carcinoma - a systematic review. Radiother Oncol. \n                           110, 81\u201390 (2014).","journal-title":"Radiother Oncol."},{"key":"7752_CR15","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s12149-013-0765-x","volume":"27","author":"A Hanamoto","year":"2013","unstructured":"Hanamoto, A. et al. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer. Ann Nucl Med. \n                           27, 880\u2013885 (2013).","journal-title":"Ann Nucl Med."},{"key":"7752_CR16","first-page":"360","volume":"24","author":"S Carsons","year":"1997","unstructured":"Carsons, S. The association of malignancy with rheumatic and connective tissue diseases. Semin Oncol. \n                           24, 360\u2013372 (1997).","journal-title":"Semin Oncol."},{"key":"7752_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","volume":"17","author":"TA Simon","year":"2015","unstructured":"Simon, T. A., Thompson, A., Gandhi, K. K., Hochberg, M. C. & Suissa, S. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther. \n                           17, 212 (2015).","journal-title":"Arthritis Res Ther."},{"key":"7752_CR18","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1136\/ard.2010.149419","volume":"70","author":"X Mariette","year":"2011","unstructured":"Mariette, X. et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Ann Rheum Dis. \n                           70, 1895\u20131904 (2011).","journal-title":"Ann Rheum Dis."},{"key":"7752_CR19","doi-asserted-by":"publisher","first-page":"e0122964","DOI":"10.1371\/journal.pone.0122964","volume":"10","author":"L Cao","year":"2015","unstructured":"Cao, L. et al. Systemic lupus erythematous and malignancy risk: a meta-analysis. PLoS One. \n                           10, e0122964 (2015).","journal-title":"PLoS One."},{"key":"7752_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00432-015-2032-0","volume":"142","author":"S Mao","year":"2016","unstructured":"Mao, S., Shen, H. & Zhang, J. Systemic lupus erythematosus and malignancies risk. J Cancer Res Clin Oncol. \n                           142, 253\u2013262 (2016).","journal-title":"J Cancer Res Clin Oncol."},{"key":"7752_CR21","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/S1470-2045(15)00417-9","volume":"17","author":"N Giaj-Levra","year":"2016","unstructured":"Giaj-Levra, N. et al. Radiotherapy in patients with connective tissue diseases. Lancet Oncol. \n                           17, e109\u2013117 (2016).","journal-title":"Lancet Oncol."},{"key":"7752_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/MLG.0b013e31815abf4c","volume":"118","author":"SH Engel","year":"2008","unstructured":"Engel, S. H., Hullar, T. E., Adkins, D. R., Thorstad, W. L. & Sunwoo, J. B. Temporal relationship between antitumor necrosis factor-alpha antibody therapy and recrudescence of head and neck squamous cell carcinoma. Laryngoscope. \n                           118, 450\u2013452 (2008).","journal-title":"Laryngoscope."},{"key":"7752_CR23","doi-asserted-by":"publisher","first-page":"e0143286","DOI":"10.1371\/journal.pone.0143286","volume":"10","author":"C Phillips","year":"2015","unstructured":"Phillips, C., Zeringue, A. L., McDonald, J. R., Eisen, S. A. & Ranganathan, P. Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis. PLoS One. \n                           10, e0143286 (2015).","journal-title":"PLoS One."},{"key":"7752_CR24","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1001\/archinte.168.18.2033","volume":"168","author":"MA Raji","year":"2008","unstructured":"Raji, M. A., Kuo, Y. F., Freeman, J. L. & Goodwin, J. S. Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care. Arch Intern Med. \n                           168, 2033\u20132040 (2008).","journal-title":"Arch Intern Med."},{"key":"7752_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/1097-0142(19930715)72:2<594::AID-CNCR2820720243>3.0.CO;2-#","volume":"72","author":"JS Goodwin","year":"1993","unstructured":"Goodwin, J. S., Hunt, W. C. & Samet, J. M. Determinants of cancer therapy in elderly patients. Cancer. \n                           72, 594\u2013601 (1993).","journal-title":"Cancer."},{"key":"7752_CR26","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/jnci\/88.15.1031","volume":"88","author":"JS Goodwin","year":"1996","unstructured":"Goodwin, J. S., Samet, J. M. & Hunt, W. C. Determinants of survival in older cancer patients. J Natl Cancer Inst. \n                           88, 1031\u20131038 (1996).","journal-title":"J Natl Cancer Inst."},{"key":"7752_CR27","doi-asserted-by":"publisher","first-page":"e0159734","DOI":"10.1371\/journal.pone.0159734","volume":"11","author":"Y Libert","year":"2016","unstructured":"Libert, Y. et al. Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival? PLoS One. \n                           11, e0159734 (2016).","journal-title":"PLoS One."},{"key":"7752_CR28","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/lary.24719","volume":"124","author":"MS Tiwana","year":"2014","unstructured":"Tiwana, M. S. et al. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years. Laryngoscope. \n                           124, 2287\u20132291 (2014).","journal-title":"Laryngoscope."},{"key":"7752_CR29","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00405-015-3699-1","volume":"273","author":"MS Patrucco","year":"2016","unstructured":"Patrucco, M. S. & Aramendi, M. V. Prognostic impact of second primary tumors in head and neck cancer. Eur Arch Otorhinolaryngol. \n                           273, 1871\u20131877 (2016).","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"7752_CR30","doi-asserted-by":"crossref","unstructured":"Yamashita, T. et al. Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer. Asia Pac J Clin Oncol., doi:10.1111 (2016).","DOI":"10.1111\/ajco.12599"},{"key":"7752_CR31","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson, M., Szatrowski, T. P., Peterson, J. & Gold, J. Validation of a combined comorbidity index. J Clin Epidemiol. \n                           47, 1245\u20131251 (1994).","journal-title":"J Clin Epidemiol."},{"key":"7752_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/hed.23360","volume":"36","author":"S Habbous","year":"2014","unstructured":"Habbous, S. et al. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status. Head Neck \n                           36, 802\u2013810 (2014).","journal-title":"Head Neck"},{"key":"7752_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/cas.12369","volume":"105","author":"H Maruyama","year":"2014","unstructured":"Maruyama, H. et al. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population. Cancer Sci. \n                           105, 409\u2013417 (2014).","journal-title":"Cancer Sci."},{"key":"7752_CR34","unstructured":"Leslie, H. S., Mary, K. G. & Christian, W. TNM Classification of Malignant Tumours 7th Edition (Wiley-Blackwell 2009)."},{"key":"7752_CR35","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1002\/cam4.882","volume":"5","author":"I Gollnitz","year":"2016","unstructured":"Gollnitz, I. et al. Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany. Cancer Med. \n                           5, 3260\u20133271 (2016).","journal-title":"Cancer Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07752-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07752-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07752-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:00:50Z","timestamp":1671782450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07752-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["7752"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-07752-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]},"assertion":[{"value":"24 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7297"}}